NCT07100522

Brief Summary

The research will produce clinical effectiveness performance metrics using standardised procedures of the Nuance Audio hearing device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2025

Completed
27 days until next milestone

Study Start

First participant enrolled

June 11, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2025

Completed
Last Updated

September 5, 2025

Status Verified

August 1, 2025

Enrollment Period

3 months

First QC Date

May 15, 2025

Last Update Submit

August 28, 2025

Conditions

Keywords

Nuance Audio hearing device, speech in noise, hearing difficultiesmild to moderate

Outcome Measures

Primary Outcomes (1)

  • Speech intellegibility testing (Matrix test) with and without device

    Conducted in both quiet and noise using validated Australian English BKB sentence materials.

    Day 1

Secondary Outcomes (1)

  • Real-world assessments

    day 1

Other Outcomes (3)

  • Self-reported measures

    Day 1

  • Self-reported measures

    day 1

  • Self-reported measures

    day 1

Study Arms (1)

Clinical performance speech intelligibility with Hearing aid in spectacle frame form factor

OTHER

This study uses a within-subjects design in which participants complete assessments in both unaided and aided conditions, using the Nuance Audio Glasses as the investigational hearing aid device. Each participant attends two sessions at the National Acoustic Laboratories (NAL), with testing conducted in controlled and real-world environments. Research methods include: Audiometric assessments: Pure-tone audiometry, tympanometry, and Real Ear Measurements (REMs). Speech perception testing: Conducted in both quiet and noise using validated Australian English BKB sentence materials. Real-world assessments: Moderated walking tour in various acoustic settings (e.g., quiet rooms, traffic noise, multi-talker babble). Self-reported measures: Questionnaires assessing hearing difficulty (HHIE-S), listening goals (COSI), perceived benefit (IOI-HA), and device preference and satisfaction.

Device: Hearing aid in spectacle frame form factorDevice: hearing aid

Interventions

eyewear frames embedded with groundbreaking technology which seamlessly integrate an air conduction hearing aid (over-the-counter "OTC", in the United States) intended to amplify sound for adult users (18yrs and older) with a perceived mild to moderate hearing impairment. Nuance Audio Glasses may, if necessary, be used in association with prescription lenses for those adults who also require correction of visual defects. Nuance Audio Glasses can be worn all day and can be easily configured via the App to adapt to any situation, from business meetings to family time.

Clinical performance speech intelligibility with Hearing aid in spectacle frame form factor

Hearing aid in spectacle frame form factor

Clinical performance speech intelligibility with Hearing aid in spectacle frame form factor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Native English speakers
  • Self-reported hearing or listening difficulties
  • No need for prescription lenses (contact lenses acceptable)
  • Ability to use smartphones and complete online surveys
  • Willingness and ability to attend two in-person research appointments

You may not qualify if:

  • Active ear disease, occluding cerumen, or any of the FDA "red flag" conditions
  • Hearing asymmetry or sudden hearing changes
  • Requirement for prescription eyewear (due to device form factor)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Acoustic Laboratories

Macquarie Park, New South Wales, 2109, Australia

Location

MeSH Terms

Conditions

Hearing Loss

Interventions

Hearing Aids

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Wearable Electronic DevicesElectrical Equipment and SuppliesEquipment and SuppliesSensory Aids

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: post-market interventional, usability
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2025

First Posted

August 3, 2025

Study Start

June 11, 2025

Primary Completion

August 28, 2025

Study Completion

August 28, 2025

Last Updated

September 5, 2025

Record last verified: 2025-08

Locations